Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness
Clardibine Approved for Relapsing, Secondary Progressive MS, Cervella Cranial Electrotherapy Approved for Insomnia, and Management of Stroke With Tandem Occlusion
Gottlieb Resignation, Priority Review Granted to Galcanezumab for Prevention of Episodic Cluster Headache, Neurologists Treating MS Deviate From DMT Use